Tarsus Pharmaceuticals, Inc. short interest in 2022
In 2022, Tarsus Pharmaceuticals, Inc.'s disclosed short interest ran from 1.56% of shares outstanding on 14 Jan 2022 to 3.89% on 30 Dec 2022, a change of +2.33 percentage points. The year's high was 6.36% on 15 Jul 2022 and its low 1.56% on 14 Jan 2022, averaging 3.74% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.21 days on 14 Oct 2022. Full history: Tarsus Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 1.56% (14 Jan 2022)
- End of year
- 3.89% (30 Dec 2022)
- Change
- +2.33 pp
- High
- 6.36% (15 Jul 2022)
- Low
- 1.56% (14 Jan 2022)
- Average
- 3.74%
- Highest days to cover
- 25.21 (14 Oct 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 1.56% | 18.45 | |
| 31 Jan 2022 | 1.60% | 9.05 | |
| 15 Feb 2022 | 1.70% | 10.18 | |
| 28 Feb 2022 | 1.87% | 7.22 | |
| 15 Mar 2022 | 1.95% | 16.31 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 2.65% | 9.86 | |
| 14 Apr 2022 | 2.84% | 17.52 | |
| 29 Apr 2022 | 2.75% | 11.98 | |
| 13 May 2022 | 1.87% | 1.00 | results (8-K), 10-Q filed |
| 31 May 2022 | 2.11% | 2.62 | |
| 15 Jun 2022 | 3.08% | 3.40 | |
| 30 Jun 2022 | 5.90% | 3.78 | |
| 15 Jul 2022 | 6.36% | 14.53 | |
| 29 Jul 2022 | 6.14% | 17.60 | |
| 15 Aug 2022 | 4.70% | 16.79 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 4.70% | 15.94 | |
| 15 Sep 2022 | 4.69% | 13.55 | |
| 30 Sep 2022 | 5.58% | 11.14 | |
| 14 Oct 2022 | 5.64% | 25.21 | |
| 31 Oct 2022 | 5.59% | 24.58 | |
| 15 Nov 2022 | 4.77% | 9.70 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 4.60% | 13.49 | |
| 15 Dec 2022 | 3.28% | 10.45 | |
| 30 Dec 2022 | 3.89% | 7.13 |
See also: Tarsus Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.